FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211505845> ?p ?o ?g. }

• W3211505845 abstract "WT2725 is a Wilms' tumor gene 1 (WT1)-derived-oligopeptide vaccine designed to induce WT1-specific cytotoxic T-lymphocytes against WT1+ tumors in human leukocyte antigen (HLA)-A*0201+ and/or HLA-A*0206+ patients. Here, we report the results of a phase I study of WT2725. In this phase I, open-label, dose-escalation and expansion two-part study, the WT2725 dosing emulsion was administered as a monotherapy to patients with advanced malignancies known to overexpress WT1, including glioblastoma. In part 1, 44 patients were sequentially allocated to four doses: 0.3 mg (n = 5), 0.9 mg (n = 5), 3 mg (n = 6), and 9 mg (n = 28). In part 2, 18 patients were allocated to two doses: 18 mg (n = 9) and 27 mg (n = 9). No dose-limiting toxicities were observed, so the maximum tolerated dose was not reached. Median progression-free survival was 58 (95% confidence interval [CI] 56-81) days (~ 2 months) across all patients with solid tumors; median overall survival was 394 days (13.0 months) (95% CI 309-648). Overall immune-related response rate in solid tumor patients was 7.5% (95% CI 2.6-19.9); response was most prominent in the glioblastoma subgroup. Overall, 62.3% of patients were considered cytotoxic T-lymphocyte responders; the proportion increased with increasing WT2725 dosing emulsion dose. WT2725 dosing emulsion was well tolerated. Preliminary tumor response and biological marker data suggest that WT2725 dosing emulsion may exert antitumor activity in malignancies known to overexpress the WT1 protein, particularly glioblastoma, and provide a rationale for future clinical development.Trial registration: NCT01621542." @default.
• W3211505845 created "2021-11-22" @default.
• W3211505845 creator A5005308006 @default.
• W3211505845 creator A5012366234 @default.
• W3211505845 creator A5013512751 @default.
• W3211505845 creator A5013874360 @default.
• W3211505845 creator A5026095888 @default.
• W3211505845 creator A5029868700 @default.
• W3211505845 creator A5044544424 @default.
• W3211505845 creator A5045197829 @default.
• W3211505845 creator A5050603971 @default.
• W3211505845 creator A5062289529 @default.
• W3211505845 creator A5063863193 @default.
• W3211505845 creator A5067588413 @default.
• W3211505845 creator A5079417201 @default.
• W3211505845 creator A5084461279 @default.
• W3211505845 date "2021-11-16" @default.
• W3211505845 modified "2023-10-02" @default.
• W3211505845 title "A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies" @default.
• W3211505845 cites W1537392447 @default.
• W3211505845 cites W167457106 @default.
• W3211505845 cites W1954448220 @default.
• W3211505845 cites W1965615377 @default.
• W3211505845 cites W1971454506 @default.
• W3211505845 cites W1978607297 @default.
• W3211505845 cites W1983398046 @default.
• W3211505845 cites W1992343552 @default.
• W3211505845 cites W2008963715 @default.
• W3211505845 cites W2013887826 @default.
• W3211505845 cites W2014434555 @default.
• W3211505845 cites W2030922808 @default.
• W3211505845 cites W2046064533 @default.
• W3211505845 cites W2051239631 @default.
• W3211505845 cites W2062024852 @default.
• W3211505845 cites W2062923894 @default.
• W3211505845 cites W2073173960 @default.
• W3211505845 cites W2073911364 @default.
• W3211505845 cites W2080387155 @default.
• W3211505845 cites W2082226454 @default.
• W3211505845 cites W2083802138 @default.
• W3211505845 cites W2093259391 @default.
• W3211505845 cites W2097091168 @default.
• W3211505845 cites W2097728086 @default.
• W3211505845 cites W2104438003 @default.
• W3211505845 cites W2111137187 @default.
• W3211505845 cites W2118288012 @default.
• W3211505845 cites W2118293627 @default.
• W3211505845 cites W2121305084 @default.
• W3211505845 cites W2131681495 @default.
• W3211505845 cites W2143476703 @default.
• W3211505845 cites W2145952607 @default.
• W3211505845 cites W2146230061 @default.
• W3211505845 cites W2148301776 @default.
• W3211505845 cites W2161872048 @default.
• W3211505845 cites W2187274214 @default.
• W3211505845 cites W2428958921 @default.
• W3211505845 cites W2474510365 @default.
• W3211505845 cites W2523328832 @default.
• W3211505845 cites W2560031831 @default.
• W3211505845 cites W2577801124 @default.
• W3211505845 cites W2587965830 @default.
• W3211505845 cites W2758938747 @default.
• W3211505845 cites W2782566786 @default.
• W3211505845 cites W2788365551 @default.
• W3211505845 cites W2896393991 @default.
• W3211505845 cites W2901054757 @default.
• W3211505845 cites W2911871569 @default.
• W3211505845 cites W3035825204 @default.
• W3211505845 cites W4229854891 @default.
• W3211505845 cites W4231722547 @default.
• W3211505845 cites W2126828680 @default.
• W3211505845 cites W2597563747 @default.
• W3211505845 doi "https://doi.org/10.1038/s41598-021-01707-3" @default.
• W3211505845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8595891" @default.
• W3211505845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34785698" @default.
• W3211505845 hasPublicationYear "2021" @default.
• W3211505845 type Work @default.
• W3211505845 sameAs 3211505845 @default.
• W3211505845 citedByCount "4" @default.
• W3211505845 countsByYear W32115058452022 @default.
• W3211505845 countsByYear W32115058452023 @default.
• W3211505845 crossrefType "journal-article" @default.
• W3211505845 hasAuthorship W3211505845A5005308006 @default.
• W3211505845 hasAuthorship W3211505845A5012366234 @default.
• W3211505845 hasAuthorship W3211505845A5013512751 @default.
• W3211505845 hasAuthorship W3211505845A5013874360 @default.
• W3211505845 hasAuthorship W3211505845A5026095888 @default.
• W3211505845 hasAuthorship W3211505845A5029868700 @default.
• W3211505845 hasAuthorship W3211505845A5044544424 @default.
• W3211505845 hasAuthorship W3211505845A5045197829 @default.
• W3211505845 hasAuthorship W3211505845A5050603971 @default.
• W3211505845 hasAuthorship W3211505845A5062289529 @default.
• W3211505845 hasAuthorship W3211505845A5063863193 @default.
• W3211505845 hasAuthorship W3211505845A5067588413 @default.
• W3211505845 hasAuthorship W3211505845A5079417201 @default.
• W3211505845 hasAuthorship W3211505845A5084461279 @default.
• W3211505845 hasBestOaLocation W32115058451 @default.
• W3211505845 hasConcept C126322002 @default.
• W3211505845 hasConcept C143998085 @default.
• W3211505845 hasConcept C154317977 @default.

• next